DRUGS MADE IN AMERICA ACQUISITION CORP.
Cash Flow Statement
| Line Item | FY2025 |
|---|---|
| Operating Activities | |
| Net Income | $5.9M |
| Depreciation & Amortization | — |
| Depreciation | — |
| Amortization | — |
| Stock-Based Compensation | — |
| Net Cash from Operating Activities | $-539.2K |
| Investing Activities | |
| Capital Expenditures | — |
| Business Acquisitions | — |
| Net Cash from Investing Activities | $-231.2M |
| Financing Activities | |
| Dividends Paid | — |
| Stock Repurchases | — |
| Net Cash from Financing Activities | $231.7M |
| Net Change in Cash | — |
| Free Cash Flow | — |